| AVAPRITINIB | None | ||
| 100MG, 200MG, 300MG, 25MG, 50MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| AYVAKIT is a kinase inhibitor indicated for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations. | |||
|
Yes
| |||
| AYVAKIT | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 |
|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||
| ************ ****** *** ******** ********* ******* ** *** | ************ ****** *** ******** ********* ******* ** *** | ************ ****** *** ******** ********* ******* ** *** | ************ ****** *** ******** ********* ******* ** *** | *********** ***** ** (*)-*-(*-************)-*-(*-(*-(*-(*-******-**-*******-*-**)*******[*,*- *][*,*,*]*******-*-**)***********)-*********-*-**)*****-*-***** *** ******* ** ****** | *********** ***** ** (*)-*-(*-************)-*-(*-(*-(*-(*-******-**-*******-*-**)*******[*,*-*][*,*,*]*******-*-**)***********)-*********-*-**)*****-*-***** *** ******* ** ****** | *********** ***** ** (*)-*-(*-************)-*-(*-(*-(*-(*-******-**-*******-*-**)*******[*,*-*][*,*,*]*******-*-**)***********)-*********-*-**)*****-*-***** *** ******* ** ****** | ****** ******** ** (*)-*-(*-************)-*-(*-(*-(*-(*-******-**-*******-*-**)*******[*,*-*][*,*,*]*******-*-**)***********)-*********-*-**)*****-*-***** *** ********* ** ******** ******** ************ |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|